Sort   by:  
 Page size 
UnknownSafety and tolerability of bireociclib for the treatment of advanced solid tumors as monotherapy and in combination with endocrine therapy: a multicenter, open-label, phase 1 clinical trial.
Not available
S-EPMC12505607 | biostudies-literature
UnknownAn open-label, single-arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR-positive, HER2-negative advanced breast cancer patients: BRIGHT-1 trial.
Not available
S-EPMC12187580 | biostudies-literature
UnknownMucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical Trial.
Not available
S-EPMC8317206 | biostudies-literature
UnknownS-1/temozolomide versus S-1/temozolomide plus thalidomide in advanced pancreatic and non-pancreatic neuroendocrine tumours (STEM): A randomised, open-label, multicentre phase 2 trial.
Not available
S-EPMC9520203 | biostudies-literature
UnknownBireociclib plus fulvestrant for HR+/HER2- advanced female breast cancer progressed on or after endocrine therapy: phase 3 BRIGHT-2 study interim analysis.
Not available
S-EPMC11982359 | biostudies-literature
Sort   by:  
 Page size